Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period.

Saved in:
Bibliographic Details
Title: Rapid Boosting of HIV-1 Neutralizing Antibody Responses in Humans Following a Prolonged Immunologic Rest Period.
Authors: Spearman P; Department of Pediatrics, Cincinnati Children's Hospital, Ohio., Tomaras GD; Department of Surgery, Duke University Medical Center, Durham, North Carolina., Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, North Carolina., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Elizaga ML; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Ferrari G; Department of Surgery, Duke University Medical Center, Durham, North Carolina., Alam SM; Department of Surgery, Duke University Medical Center, Durham, North Carolina., Isaacs A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Ahmed H; Department of Biology, Emory University, Atlanta, Georgia., Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Ouedraogo L; Division of AIDS, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Pensiero M; Division of AIDS, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Butler C; Division of AIDS, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Kalams SA; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee., Overton ET; Department of Medicine, University of Alabama at Birmingham, Cambridge, Massachusetts., Barnett SW; Novartis Vaccines, Cambridge, Massachusetts.
Corporate Authors: HVTN 088 Protocol Team and the NIH/NIAID HIV Vaccine Trials Network
Source: The Journal of infectious diseases [J Infect Dis] 2019 May 05; Vol. 219 (11), pp. 1755-1765.
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first